You are here

Rocket Pharmaceuticals

Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward

Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward

Fierce Biotech

Rocket Pharmaceuticals

clinical trials

Flag link:

Rocket is bringing lenti back

Rocket is bringing lenti back

EP Vantage

Rocket Pharmaceuticals

Flag link:

New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns

New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns

Fierce Biotech

Rocket Pharmaceuticals

clinical trials

Flag link:

Rocket inks Renovacor buyout to propel its heart disease gene therapy ambitions

Rocket inks Renovacor buyout to propel its heart disease gene therapy ambitions

Fierce Biotech

Rocket Pharmaceuticals

Flag link:

100% overall survival data for gene therapy fuel Rocket for flight to regulators

100% overall survival data for gene therapy fuel Rocket for flight to regulators

Fierce Biotech

Rocket Pharmaceuticals

Leukocyte Adhesion Deficiency-I

Flag link:

FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing

FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing

Fierce Biotech

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline

Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline

Pharmaceutical Business Review

Rocket Pharmaceuticals

drug manufacturing

Flag link:

Rocket Pharmaceuticals receives FDA fast track designation for RP-L401 gene therapy for infantile malignant osteopetrosis

Rocket Pharmaceuticals receives FDA fast track designation for RP-L401 gene therapy for infantile malignant osteopetrosis

Pharmaceutical Business Review

Rocket Pharmaceuticals

infantile malignant osteopetrosis[]

Flag link:

Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia

Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia

Pharmaceutical Business Review

Rocket Pharmaceuticals

Flag link:

Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

Pharmaceutical Business Review

Rocket Pharmaceuticals

Flag link:

Follow-on roundup: Acadia raises $275M, Rocket pockets $55M

Follow-on roundup: Acadia raises $275M, Rocket pockets $55M

BioCentury

Acadia Pharmaceuticals

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

CP Wire

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

CP Wire

Rocket Pharmaceuticals

Leukocyte Adhesion Deficiency-I

Flag link:

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

Rocket Pharmaceuticals

Leukocyte Adhesion Deficiency-I

Flag link: